A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

Enrolling by invitation

Conditions studied: Type 2 Diabetes

In brief

The study is testing the incidence of MACE and incidence of renal events between Ozempic® users and users with other anti-diabetic medications in T2D patients. This is a retrospective study, and participants had received Ozempic or any other anti-diabetic medications.

Key facts

Study ID

NCT07456774

Run by

Novo Nordisk A/S

People needed

100000

Starts

2026-02-13

Expected to finish

2026-08-31

Last updated by the study team

2026-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants had at least one prescription for Ozempic® or other interested anti-diabetic medications during the index identification period.
• Participants had at least one diagnosis of T2D, and had at least one of the three following T2D clinical evidence any time before or on the index date
• Participants had at least 1 all-cause visit record any time after 6 months post-index date.
• At least 18 years old at the index date.

You may not qualify if…

• Patients who have used any same anti-diabetic medications as the index treatment within 6 months before index date (e.g., patient prescribed with any Ozempic® during baseline will be excluded if the index drug is a Ozempic®)
• Patients with any diagnosis record of type 1 diabetes or gestational diabetes during whole study period.
• Patients who were pregnant during the whole study period.
• Patients who participated in any clinical trials during the whole study period.
• Patients who were diagnosed with medullary thyroid carcinoma or multiple endocrine neoplasia type II (MEN2) during the whole study period.

Where it is running

• NIS- Tianjin Medical University Chu Hsien-I Memorial Hospital-Department of Endocrinology — Tianjin, Tianjin Municipality, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.